GL1X · GenesisL1 explorer

MolNFT v1 · #172817 · protein

Studies towards a reversible EGFR C797S triple mutant inhibitor series

7AEM · Epidermal growth factor receptor: “Studies towards a reversible EGFR C797S triple mutant inhibitor series”. X-ray diffraction, 1 ligand (6GY), 2 pockets (best druggability 0.63). MolNFT v1 #172817 on GenesisL1: 3D structure, binding…

PDB
7AEM
Type
protein
Length
312 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Epidermal growth factor receptor
EC
2.7.10.1
UniProt
P00533
Ligands
6GY
Pockets
2 · best druggability 0.63

Structure

x-ray diffraction · 1 distinct chain · 35% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEpidermal growth factor receptor (EC 2.7.10.1)protein31235% helix, 18% strandP00533

Ligands and binding sites

  • 6GY · 5-chloro-N~4~-[2-(dimethylphosphoryl)phenyl]-N~2~-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13830.630.78456GY
2630.310.7514empty

Compared structures

  • 7AEM · Studies Towards a Reversible EGFR C797S Triple Mutant Inhibitor Series · the same entry in another collection · chain A against A, TM-score 1.00
  • P00533 · AlphaFold monomer V2.0 prediction for epidermal growth factor receptor (P00533) · a predicted model of the same protein · chain A against A, TM-score 0.91

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.